Regulatory
Breakthrough Therapy Designation
An FDA designation for drugs intended for serious conditions where preliminary evidence shows substantial improvement over existing therapies. Provides intensive FDA guidance and potential expedited review.
See How Breakthrough Therapy Designation Affects Deal Economics
Model deal terms with real benchmark data from 3,000+ biopharma transactions.